A. Ozderya Et Al. , "Biochemical and pathologic factors affecting technetium-99m-methoxyisobutylisonitrile imaging results in patients with primary hyperparathyroidism," ANNALS OF NUCLEAR MEDICINE , vol.32, no.4, pp.250-255, 2018
Ozderya, A. Et Al. 2018. Biochemical and pathologic factors affecting technetium-99m-methoxyisobutylisonitrile imaging results in patients with primary hyperparathyroidism. ANNALS OF NUCLEAR MEDICINE , vol.32, no.4 , 250-255.
Ozderya, A., Temizkan, S., Gul, A. E., Ozugur, S., Cetin, K., & Aydin, K., (2018). Biochemical and pathologic factors affecting technetium-99m-methoxyisobutylisonitrile imaging results in patients with primary hyperparathyroidism. ANNALS OF NUCLEAR MEDICINE , vol.32, no.4, 250-255.
Ozderya, Aysenur Et Al. "Biochemical and pathologic factors affecting technetium-99m-methoxyisobutylisonitrile imaging results in patients with primary hyperparathyroidism," ANNALS OF NUCLEAR MEDICINE , vol.32, no.4, 250-255, 2018
Ozderya, Aysenur Et Al. "Biochemical and pathologic factors affecting technetium-99m-methoxyisobutylisonitrile imaging results in patients with primary hyperparathyroidism." ANNALS OF NUCLEAR MEDICINE , vol.32, no.4, pp.250-255, 2018
Ozderya, A. Et Al. (2018) . "Biochemical and pathologic factors affecting technetium-99m-methoxyisobutylisonitrile imaging results in patients with primary hyperparathyroidism." ANNALS OF NUCLEAR MEDICINE , vol.32, no.4, pp.250-255.
@article{article, author={Aysenur Ozderya Et Al. }, title={Biochemical and pathologic factors affecting technetium-99m-methoxyisobutylisonitrile imaging results in patients with primary hyperparathyroidism}, journal={ANNALS OF NUCLEAR MEDICINE}, year=2018, pages={250-255} }